Thrombosis in Patients with the Lupus Anticoagulant
Authors:
- 1 February 1980
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 92 (2_Part_1) , 156-159
Abstract
A retrospective study was carried out to determine the frequency of thrombosis in patients with the lupus anticoagulant. Thirty-five patients fulfilled laboratory criteria for the diagnosis of the lupus anticoagulant. Eight of these patients had evidence of clinically significant thrombosis while their plasma showed a prolonged partial thromboplastin time due to the anticoagulant. Four of the patients wity thrombosis had concurrent autoimmune disease and three other patients were receiving phenothiazine medication. Moderate thrombocytopenia was noted in four patients with thrombosis. None of the patients with the lupus anticoagulant bled abnormally. This study suggests that patients with the lupus anticoagulant may be at increased risk of thrombosis.Keywords
This publication has 7 references indexed in Scilit:
- Immunologic and Coagulation Disorders in Chlorpromazine-Treated PatientsAnnals of Internal Medicine, 1979
- Recurrent Venous Thrombosis with a “Lupus” Coagulation Inhibitor in the Absence of Systemic LupusAustralian and New Zealand Journal of Medicine, 1977
- The lupus anticoagulantArthritis & Rheumatism, 1976
- A clinical study of the lupus anticoagulantBlood, 1976
- Chlorpromazine-Induced Systemic Lupus ErythematosusJAMA, 1972
- RECURRENT THROMBOSIS IN A YOUNG WOMAN WITH A CIRCULATING ANTICOAGULANT DIRECTED AGAINST FACTORS XI AND XIIActa Medica Scandinavica, 1972
- CHLORPROMAZINE‐INDUCED ANTINUCLEAR FACTORSActa Medica Scandinavica, 1970